Molecule to Market: Inside the outsourcing space

Roundtable: Latest trends in CDMO

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC, Mark Quick, Executive Vice President Corporate Development at Recipharm AB, Lynn Allen, Vice President Of Business Development at MedPharm Ltd, Alfredo Gomez, Head of Site at Idifarma, and Rick Seibert, Sr. Vice President, Innovation and Technology Services at Sharp Clinical Services.

This session will involve a wider discussion around COVID-19 related trends and also natural progression in the CDMO space. We will begin by exploring recurring trends involving futureproofing and digitisation across the industry including a growing need for automation.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Roundtable: Clinical trials in 2020 and beyond

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Torkel Gren, Senior Director, Technology Officer & Strategic Investments at Recipharm, Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical Services, Vincent Dunne, CEO at Wasdell Group and Stephen Rode, Business Development Manager for Lonza Pharma and Biotech.

We’ll explore the impact of COVID-19 on traditional clinical trial processes to highlight how the industry has adapted. We will cover topics including ‘direct to patient treatment’ and trends that highlight a move away from the ‘norm’ in order to survive and thrive.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Roundtable: Global geography and the pharma and bio supply chain

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, Dan Stanton, Founder and Editor of Bioprocess Insider and Stefano Console, Senior Advisor and Founder at Oriento.

Join us as we discuss the impact of COVID-19 on the pharma and bio supply chain. We explore the real human challenges experienced in the face of a global pandemic and the impact these challenges have had on business. We also discuss concerns around safety and environmental impacts relating to materials suppliers.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Scientist & champion powerlifter

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shane Needham, Chief Founding Scientist, Director of the Board and Owner at Alturas Analytics, Inc. With a PHD in chemistry, Dr. Needham has spent almost 30 years in the sector. He started his career at Pfizer and went on to found his own company, Alturas Analytics, which focuses on solving complex bioanalytical problems. He has over 100 publications and external presentations in the area of LC/MS and leads a team of world class scientists. And if this isn’t impressive enough, beyond work, Shane is a podcaster, TEDx motivational speaker, champion bodybuilder, champion powerlifter and philanthropist. 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain (and a whole loaf more) with Shane, covering the importance of coaching as a leader and setting the best example you can. Shane gives listeners life lessons in relationships, giving it your all, and in succeeding and failing. Raman and Shane speak about the impact of Covid-19 in accelerating the ‘things that would have happened eventually’ in the pharma and biotech analytical testing space. And finally Shane speaks on the parallels between success in business and success in hobbies, we’ll give you a hint, consistency is the most important factor.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

From fax to SaaS: digitising the the pharma supply chain

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe, CEO at Veratrak. A graduate of Toronto and Oxford University, Jason was recently named as one of Forbes 30 Under 30 and has also advised the WHO and EU. Today, his business is one of the fastest growing tech companies in the life science space.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering the impact Covid-19 has had on accelerating the digitisation of the global pharmaceutical supply chain. Jason speaks about dealing with inertia and how it is now more clear than ever; the old way of doing things is not fit for our modern world. Lastly, Jason touches on the importance of aiming for less stock outs, faster leader times, more secure documentation and most importantly, better patient outcomes. 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Successful outsourcing partnerships: now and then

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian, Senior Vice President, Regulatory at Lyndra Therapeutics. To say Mary has an impressive track record is an understatement. Across the last three decades she has worked for some of the biggest pharmaceutical companies in the world including Janssen and Bristol Myers Squibb before moving onto several fast growing biotech companies including Ironwood, Cyclerion and now Lyndra in senior regulatory and quality roles. She’s also a guest lecturer, a mentor to many, and a trustee for the Center for Great Expectations in New Jersey. 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Mary Christian. In this episode, Mary reflects on the main differences in working with small, nimble bio and pharma companies compared to larger more structured organizations, particularly commenting on the different ways vendors are selected. She also addressed the major shift in types of relationships sponsors and vendors have with each other as she has seen things become less transactional over time. She gives valuable advice to vendors on how to get the most out of your partnership from the very beginning while explaining what a good and bad partnership experience looks like from her perspective as a sponsor. Mary gives advice based on her experience as a successful leader in the space and explains the value in having a support system at work and at home. She also highlights how important it is, for women especially, to not opt out of opportunities to further their career. Lastly Mary speaks about The Center for Great Expectations, an organization which empowers women and families battling mental health and substance disorders to break the cycle and provide better lives for their children.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Old world solutions won’t work for new world problems

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Lesina, Global Marketing Director of Pharma & Nutrition, Capsules and Health Ingredients at Lonza. A multilingual, international marketing leader, Sara oversees the global marketing and product line management team for the capsule business of Lonza, Capsugel^®.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Sara Lesina, covering how diversity in her life and career has given her a much more open, flexible and balanced view of the world and how it has helped her as a leader in a global pharma industry. Sara also explains the value of learning from failure and how making mistakes is part of the journey in stretching yourself to become a bolder and more confident individual. Lastly, Raman and Sara discuss the impact that COVID-19 has had on business and marketing efforts in the pharmaceutical and biotech space, making it clear that traditional solutions will not provide answers for the current and future challenges we face.

Please subscribe, and invite your industry colleagues to join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed.

Looking towards the future: A continuous mindset

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals. Like celebrated “one-club” football stars like Leo Messi at Barcelona, Alessandro Del Piero at Juventus and Steven Gerrard at Liverpool… Carl-Åke has been with Xellia since 1988. A pharmaceutical leader known for his class and commercial acumen, Carl‑Åke started in a finance position. He was soon diversifying into other areas and running various divisions before rising to the top as global CEO of a business that employs 1,800 people.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Carl-Åke Carlsson, covering Xellia’s journey from an API supplier to a global specialty pharma company known for novel anti-infective, life-saving medicines. Carl‑Åke speaks about his journey from his position in finance to CEO and the transformation of Xellia as a company over the years, offering advice and insight from his experiences. He explains how he has created and scaled a world-class culture using internal, cross-functional “transformers” to assist in upholding values internally and externally. He speaks about the origins of the industry-renowned DCAT and CPhI Xellia parties. And lastly, he announces some exciting news about Xellia and their plans for expansion.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Life in a boutique, specialist CDMO

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal, Business Development Director at IDIFARMA. A student of law and business, Manuel has carved a very impressive career in the outsourcing space all despite having no formal pharma and science background! He has spent the last decade helping take a little known, local formulation development firm in Northern Spain into a global, specialist CDMO.

 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Manuel, covering the transition from development and clinical manufacturing to commercial production. Manuel gives us the inside scoop on what it’s like being a boutique, niche CDMO with in-demand high potency and spray drying capabilities versus serving as a “one-stop-shop”. He discusses the value of curiosity, resilience, continuous learning and being humble in carving a career in pharma, and how he has found success without a science background. Lastly, Raman and Manuel speak on the reasons we may see geographically closer and more controlled supply chains in the post Covid-19 world.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.

Owning your authenticity

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults global health companies ranging from spin outs to multinational companies on how to fast track their technology to market. Claire has worked for Pfizer, GSK, Oxford, Pharma Science and The Royal Pharma Society to name a few. 

 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering the value of standing out in a crowd, being memorable and owning your authenticity, especially as a female in the pharma and biotech sector. Claire shares what she has learned from playing elite level football for many years and how she has been able to apply these lessons to business strategy, communications, winning and being a team. She and Raman also discuss a continued trend in outsourcing growth, with biotech companies opting for parallel manufacturing with CDMOs to mitigate risk in reaching key milestones. Lastly Claire champions several notable female causes and Raman makes a live donation on air!

 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.